Organization Overview
Alternative names
abiraterone (zytiga) (2 trials)
aldesleukin (Proleukin) (3 trials)
alendronic acid (fosamax) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (9 trials)
anastrozole (arimidex) (8 trials)
atezolizumab (Tecentriq) (9 trials)
atrasentan hydrochloride (1 trial)
autologous hematopoietic stem cells (14 trials)
azacitidine (vidaza) (6 trials)
bacille calmette-guerin (1 trial)
bevacizumab (avastin) (16 trials)
bicalutamide (casodex) (11 trials)
bleomycin (blenoxane) (5 trials)
bortezomib (velcade) (10 trials)
brentuximab vedotin (adcetris) (1 trial)
bupropion (wellbutrin) (1 trial)
buserelin (receptal) (2 trials)
capecitabine (xeloda) (14 trials)
carboplatin (paraplatin) (29 trials)
cetuximab (erbitux) (14 trials)
ciprofloxacin (cipro) (1 trial)
cisplatin (platinol) (51 trials)
conjugated equine estrogens (Premarin) (1 trial)
cyclophosphamide (cytoxan) (52 trials)
cyclosporine (sandimmune) (6 trials)
cytarabine (cytosar-u) (20 trials)
dacarbazine (dtic-dome) (5 trials)
daratumumab (darzalex) (1 trial)
daunorubicin (cerubidine) (9 trials)
decitabine (dacogen) (1 trial)
degarelix acetate (firmagon) (1 trial)
docetaxel (taxotere) (35 trials)
doxorubicin (Doxil) (48 trials)
duloxetine (Cymbalta) (1 trial)
durvalumab (imfinzi) (3 trials)
eflornithine (ornidyl) (1 trial)
epirubicin (ellence) (1 trial)
erlotinib (tarceva) (14 trials)
estramustine (emcyt) (4 trials)
etoposide (vepesid) (31 trials)
everolimus (zortress) (5 trials)
exemestane (aromasin) (5 trials)
Filgrastim (neupogen) (5 trials)
fludarabine (fludara) (4 trials)
fluorouracil (efudex) (33 trials)
flutamide (eulexin) (6 trials)
fulvestrant (faslodex) (2 trials)
gemcitabine (gemzar) (32 trials)
gemtuzumab ozogamicin (mylotarg) (4 trials)
goserelin (zoladex) (12 trials)
histrelin (supprelin) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
idarubicin (idamycin) (2 trials)
interferon alpha-2b (Intron-A) (11 trials)
ipilimumab (yervoy) (6 trials)
irinotecan (Camptosar) (18 trials)
ketoconazole (nizoral) (2 trials)
lansoprazole (prevacid) (1 trial)
lenalidomide (revlimid) (9 trials)
leuprolide (lupron) (9 trials)
levamisole (ergamisol) (2 trials)
loperamide (imodium) (1 trial)
medroxyprogesterone (provera) (1 trial)
melphalan (alkeran) (8 trials)
mercaptopurine (purinethol) (5 trials)
metronidazole (flagyl) (1 trial)
midostaurin (rydapt) (1 trial)
mifepristone (mifeprex) (1 trial)
mitomycin (mutamycin) (3 trials)
mitoxantrone (novantrone) (4 trials)
n-(4-hydroxyphenyl)all-trans retinamide (2 trials)
naltrexone (revia) (15 trials)
nicotine (nicorette) (1 trial)
nilutamide (nilandron) (4 trials)
obinutuzumab (gazyva) (2 trials)
octreotide (sandostatin) (3 trials)
oxaliplatin (eloxatin) (12 trials)
paclitaxel (taxol) (45 trials)
pemetrexed (alimta) (11 trials)
prednisone (meticorten) (30 trials)
procaine benzylpenicillin (novocaine) (1 trial)
procarbazine (matulane) (3 trials)
ramucirumab (cyramza) (7 trials)
risedronate (actonel) (1 trial)
rituximab (rituxan) (20 trials)
sargramostim (leukine) (30 trials)
selenomethionine se-75 (1 trial)
sorafenib (nexavar) (9 trials)
tamoxifen (nolvadex) (11 trials)
tenofovir alafenamide (genvoya) (1 trial)
thalidomide (Thalomid) (8 trials)
topotecan (hycamtin) (3 trials)
tositumomab (Bexxar) (4 trials)
trastuzumab (herceptin) (6 trials)
tretinoin (Retin-A) (2 trials)
triptorelin (Trelstar) (2 trials)
venetoclax (venclexta) (4 trials)
vinblastine (velban) (9 trials)
vincristine (oncovin) (31 trials)
vinorelbine (navelbine) (9 trials)
aflibercept (zaltrap) (1 trial)
allogeneic lymphocytes (1 trial)
allopurinol (zyloprim) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
arsenic trioxide (trisenox) (2 trials)
asparaginase (elspar) (2 trials)
avelumab (bavencio) (2 trials)
belinostat (beleodaq) (1 trial)
bendamustine (treanda) (3 trials)
binimetinib (mektovi) (1 trial)
blinatumomab (blincyto) (1 trial)
cabozantinib (cometriq) (3 trials)
capmatinib (Tabrecta) (1 trial)
carfilzomib (kyprolis) (1 trial)
celecoxib (celebrex) (2 trials)
clofarabine (clolar) (2 trials)
dabrafenib (tafinlar) (2 trials)
dasatinib (sprycel) (6 trials)
dipyridamole (persantine) (1 trial)
elotuzumab (empliciti) (1 trial)
encorafenib (braftovi) (2 trials)
etaracizumab (abegrin) (1 trial)
fludeoxyglucose f-18 (1 trial)
gvax lung cancer vaccine (1 trial)
humanised anti-cd22 antibody (1 trial)
hydroxyurea (hydrea) (1 trial)
ibritumomab tiuxetan (Zevalin) (2 trials)
ibrutinib (imbruvica) (1 trial)
Isatuximab (Sarclisa) (1 trial)
ixabepilone (ixempra) (3 trials)
methylprednisolone (medrol) (2 trials)
modified vaccinia ankara-5t4 vaccine (1 trial)
mycophenolate (CellCept) (1 trial)
nelarabine (arranon) (2 trials)
olaparib (lynparza) (2 trials)
osimertinib (tagrisso) (1 trial)
pertuzumab (perjeta) (1 trial)
pravastatin (pravachol) (1 trial)
recombinant adenoviral human p53 gene (1 trial)
romidepsin (istodax) (2 trials)
ruxolitinib (jakafi) (1 trial)
sacituzumab govitecan (Trodelvy) (1 trial)
Selpercatinib (Retevmo) (2 trials)
selumetinib (Koselugo) (1 trial)
siltuximab (sylvant) (2 trials)
sulfamethoxazole (gantanol) (1 trial)
tacrolimus (prograf) (2 trials)
talazoparib (talzenna) (3 trials)
talimogene laherparepvec (Imlygic) (1 trial)
telisotuzumab (Teliso-V) (1 trial)
temozolomide (temodar) (3 trials)
temsirolimus (torisel) (3 trials)
tioguanine (Lanvis) (2 trials)
trametinib (mekinist) (4 trials)
tremelimumab (Imjudo) (1 trial)
vandetanib (caprelsa) (2 trials)
Acute Disease (Phase 1)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 3)
Adenocarcinoma, Clear Cell (Phase 2)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Adenocarcinoma, Papillary (Phase 2)
Adenoma (Phase 3)
Adrenocortical Carcinoma (Phase 2)
Amyloidosis (Phase 2)
Anus Neoplasms (Phase 3)
Arthralgia (Phase 3)
Bile Duct Neoplasms (Phase 3)
Biliary Tract Neoplasms (Phase 3)
Brain Neoplasms (Phase 1)
Breast Carcinoma In Situ (Phase 3)
Breast Neoplasms (Phase 3)
Burkitt Lymphoma (Phase 3)
Carcinoid Tumor (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Acinar Cell (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Ductal (Phase 3)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Endometrioid (Phase 2)
Carcinoma, Giant Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Large Cell (Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 2)
Cardiotoxicity (Phase 3)
Cataract (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Cholangiocarcinoma (Phase 3)
Chondrosarcoma (Phase 2)
Chordoma (Phase 2)
Choriocarcinoma (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Constipation (Phase 2)
Cystadenocarcinoma (Phase 3)
Cystadenocarcinoma, Mucinous (Phase 2)
Cystadenocarcinoma, Serous (Phase 2)
Dermatofibrosarcoma (Phase 2)
Diarrhea (Phase 3)
Endometrial Neoplasms (Phase 3)
Ependymoma (Phase 2)
Esophageal Neoplasms (Phase 2)
Eye Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Fatigue (Phase 3)
Fibroma (Phase 2)
Fibromatosis, Aggressive (Phase 2)
Fibrosarcoma (Phase 2)
Gallbladder Neoplasms (Phase 3)
Gastrointestinal Hemorrhage (Phase 2)
Gastrointestinal Stromal Tumors (Phase 3)
Gestational Trophoblastic Disease (Phase 2)
Glioblastoma (Phase 3)
Gliosarcoma (Phase 3)
Head and Neck Neoplasms (Phase 3)
Hemangiopericytoma (Phase 2)
Hemangiosarcoma (Phase 2)
Hemorrhage (Phase 2)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Hepatomegaly (Phase 2)
Hodgkin Disease (Phase 3)
Hot Flashes (Phase 3)
Hutchinson's Melanotic Freckle (Phase 2)
Hypercalcemia (Phase 3)
Hypereosinophilic Syndrome (Phase 2)
Immunoblastic Lymphadenopathy (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Infertility (Phase 3)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 1)
Intraocular Lymphoma (Phase 1)
Kidney Neoplasms (Phase 3)
Klatskin Tumor (Phase 2)
Laryngeal Diseases (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leiomyosarcoma (Phase 2)
Lentigo (Phase 2)
Leukemia (Phase 3)
Leukemia, Basophilic, Acute (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 2)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 3)
Leukemia, T-Cell (Phase 2)
Liver Diseases (Phase 1)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphadenopathy (Phase 2)
Lymphoma (Phase 3)
Lymphoma, AIDS-Related (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 1)
Macroglossia (Phase 2)
Macular Degeneration (Phase 3)
Medulloblastoma (Phase 2)
Melanoma (Phase 3)
Meningeal Neoplasms (Phase 2)
Meningioma (Phase 3)
Mesothelioma (Phase 2)
Metaplasia (Phase 2)
Mixed Tumor, Mullerian (Phase 2)
Mucositis (Phase 3)
Multiple Myeloma (Phase 3)
Mycoses (Phase 1)
Mycosis Fungoides (Phase 1)
Myelodysplastic Syndromes (Phase 3)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Unknown Primary (Phase 2)
Nerve Sheath Neoplasms (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuroendocrine Tumors (Phase 3)
Neurofibrosarcoma (Phase 2)
Neurotoxicity Syndromes (Phase 3)
Neutropenia (Phase 2)
Oligodendroglioma (Phase 3)
Oropharyngeal Neoplasms (Phase 2)
Osteoporosis (Phase 3)
Ovarian Neoplasms (Phase 3)
Paget Disease, Extramammary (Phase 2)
Pancoast Syndrome (Phase 2)
Pancreatic Neoplasms (Phase 3)
Paraganglioma (Phase 2)
Paranasal Sinus Neoplasms (Phase 2)
Penile Neoplasms (Phase 2)
Peripheral Nervous System Diseases (Phase 3)
Pheochromocytoma (Phase 3)
Philadelphia Chromosome (Phase 2)
Plasmablastic Lymphoma (Phase 3)
Plasmacytoma (Phase 3)
Precancerous Conditions (Phase 3)
Preleukemia (Phase 3)
Prostatic Intraepithelial Neoplasia (Phase 3)
Prostatic Neoplasms (Phase 3)
Pseudomyxoma Peritonei (Phase 2)
Purpura (Phase 2)
Rectal Neoplasms (Phase 3)
Rhabdomyosarcoma (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 3)
Sarcoma, Synovial (Phase 2)
Sclerosis (Phase 3)
Seminoma (Phase 2)
Sex Cord-Gonadal Stromal Tumors (Phase 2)
Sezary Syndrome (Phase 1)
Skin Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Stomach Neoplasms (Phase 2)
Syndrome (Phase 3)
Teratoma (Phase 2)
Testicular Neoplasms (Phase 3)
Thrombocytopenia (Phase 2)
Thymoma (Phase 2)
Thyroid Neoplasms (Phase 2)
Tongue Neoplasms (Phase 2)
Trophoblastic Neoplasms (Phase 2)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Uveal Neoplasms (Phase 2)
Vulvar Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)